One study found that under hyperlipidemic conditions, gut microbiota can activate B2 cells in perivascular adipose tissue, leading to increased IgG production and disease progression
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects
View DSIP (Delta Sleep-Inducing Peptide) Despite the name, DSIP does not act like a classical sedative
No reconstitution is needed for topical formulations
Foreign investing has additional risks including those associated with currency fluctuation, political and economic instability, and different accounting standards
P., & Bellamine, A